候选流感病毒与鸡胚生产对疫苗效果的影响:文献综述与专家共识
该研究采用专家共识与文献综述方法,评估鸡胚生产过程中候选流感病毒变异(抗原漂移和鸡胚适应)降低疫苗效果的机制证据。十名欧洲流感专家通过两阶段在线评估,对四个组件原则的支持文献进行评分,最终一致认为存在机制基础,尤其针对甲型H3N2毒株。
要点
- 专家一致认为鸡胚生产导致的候选流感病毒变异可降低疫苗效果,尤其甲型H3N2。
- 监测、候选疫苗病毒选择及涉及鸡胚的生产阶段最可能影响疫苗效果。
- 多数组件原则有70-90%的强或非常强支持证据。
核心结论
- 专家一致认为,由于鸡胚生产导致的候选流感病毒变异,存在降低疫苗效果的机制基础,尤其针对甲型H3N2毒株。
研究设计与样本
- 招募十名欧洲流感专家组成专家组,将研究问题分解为四个组件原则,采用新型在线两阶段评估群体认知与共识。
- 第一阶段通过文献检索和专家评估独立生成每个组件原则的支持参考文献列表。
- 第二阶段向专家分发每篇参考文献的摘要,专家用5点李克特量表评分其支持组件原则的同意程度。
主要发现
- 所有组件原则均报告有70-90%的强或非常强支持证据。
- 专家指出监测、候选疫苗病毒选择及涉及鸡胚的生产阶段最可能影响疫苗效果。
临床怎么用
- 关注鸡胚生产对疫苗效果的影响,尤其在甲型H3N2毒株的监测和候选疫苗病毒选择阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Influenza is associated with significant morbidity and mortality worldwide. Whilst vaccination is key for the prevention of influenza infection, there are many factors which may contribute to reduced vaccine effectiveness, including antigenic evolution via both antigenic drift and egg-adaptations. Due to the currently dissociated and indirect evidence supporting both the occurrence of these two phenomena in the egg-based manufacturing process and their effects on vaccine effectiveness, this topic remains a subject of debate. OBJECTIVE: To review the evidence and level of agreement in expert opinion supporting a mechanistic basis for reduced vaccine effectiveness due to egg-based manufacturing, using an expert consensus-based methodology and literature reviews. METHODS: Ten European influenza specialists were recruited to the expert panel. The overall research question was deconstructed into four component principles, which were examined in series using a novel, online, two-stage assessment of proportional group awareness and consensus. The first stage independently generated a list of supporting references for each component principle via literature searches and expert assessments. In the second stage, a summary of each reference was circulated amongst the experts, who rated their agreement that each reference supported the component principle on a 5-point Likert scale. Finally, the panel were asked if they agreed that, as a whole, the evidence supported a mechanistic basis for reduced vaccine effectiveness due to egg-based manufacturing. RESULTS: All component principles were reported to have a majority of strong or very strong supporting evidence (70-90%). CONCLUSIONS: On reviewing the evidence for all component principles, experts unanimously agreed that there is a mechanistic basis for reduced vaccine effectiveness resulting from candidate influenza virus variation due to egg-based manufacturing, particularly in the influenza A/H3N2 strain. Experts pointed to surveillance, candidate vaccine virus selection and manufacturing stages involving eggs as the most likely to impact vaccine effectiveness.
引用
- Rajaram S, Wojcik R, Moore C, et al. The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus. Vaccine. 2020. PMID: 32600916. doi:10.1016/j.vaccine.2020.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。